Episode

Psilocybin: What You Need to Know

Podcast
The Carlat Psychiatry Podcast
Published
Jun 15, 2026
Duration seconds
1114
Processing state
not_requested
Canonical source
https://www.thecarlatreport.com/blogs/2-the-carlat-psychiatry-podcast/post/6337-psilocybin-what-you-need-to-know
Audio
https://media.blubrry.com/the_carlat_psychiatry_podcast/content.blubrry.com/the_carlat_psychiatry_podcast/Psilocybin_Need_to_Know_Edit.mp3
JSON
/v1/public/podcasts/the-carlat-psychiatry-podcast-491560/episodes/psilocybin-what-you-need-to-know
Markdown
/podcast/the-carlat-psychiatry-podcast-491560/psilocybin-what-you-need-to-know.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-carlat-psychiatry-podcast-491560/episodes/psilocybin-what-you-need-to-know/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-carlat-psychiatry-podcast-491560/psilocybin-what-you-need-to-know.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Psilocybin is going mainstream: Trump has signed an executive order opening psychedelics to patients with severe mental illness, and one in eight American adults has already tried it. But as we dig into the research, a more complicated picture emerges, one that separates the profound personal experience from the clinical evidence. CME: Take the CME Post-Test for this Episode Published On: 06/15/2026 Duration: 18 minutes, 34 seconds Chris Aiken, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.